Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2002
04/24/2002CN1083436C Process for preparing 1-substoituted 4-cyano-1,2,3-triazoles
04/24/2002CN1083431C Novel heterocyclic compounds
04/24/2002CN1083430C Carbazolone derivatives
04/23/2002US6376667 Cyclization in presenc eof base
04/23/2002US6376656 Disazo dyes, triazine dyes
04/23/2002US6376527 Pyrazole derivatives-p38 map kinase inhibitors
04/23/2002US6376526 For huans, animals
04/23/2002US6376520 Pesticides
04/23/2002US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
04/23/2002US6376503 Alpha 1a adrenergic receptor antagonists
04/23/2002US6376499 Piperazine-amide compound with anticoagulant activity
04/23/2002US6376496 Inhibitors of prenyl-protein transferase
04/23/2002US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries
04/23/2002US6376484 For prevention and/or treatment of various kinds of inflammatory disease
04/23/2002US6376426 Herbicidal 3-(heterocycl-1-yl)-uracils
04/23/2002US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative
04/23/2002CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent
04/23/2002CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds
04/23/2002CA2069144C Imidazole compounds, their preparation and use
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002WO2002030912A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030908A1 Inhibitors of protein kinases
04/18/2002WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS
04/18/2002WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors
04/18/2002WO2002030890A1 Nitrogenous five-membered ring compounds
04/18/2002WO2002030886A2 Heterocyclic angiogenesis inhibitors
04/18/2002WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
04/18/2002WO2002002488A3 Methods and compounds for modulating nuclear receptor coactivator binding
04/18/2002WO2001091732A3 Medicament for combating respiratory depression
04/18/2002WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors
04/18/2002WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
04/18/2002WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/18/2002WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
04/18/2002US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
04/18/2002US20020045652 Prophylactic or therapeutic drug for renal diseases
04/18/2002US20020045650 Substituted indole proteolytic enzyme inhibitors as cancer treating agents
04/18/2002US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof
04/18/2002US20020045633 Use of moxonidine for postmyocardial infarction treatment
04/18/2002US20020045628 Antidepressants; anxiolytic agents; serotonin-affected nervous system disorders; acting at the 5-HT1a autoreceptors concommitantly with 5-HT transporters; antiserotonin agents; serotonin reuptake inhibitors; HT3 receptor antagonists
04/18/2002US20020045619 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
04/18/2002US20020045618 Heteroaryl diazacycloalkanes, their preparation and use
04/18/2002US20020044963 Cyclic AMP-specific phosphodiesterase inhibitors
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
04/18/2002CA2425416A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002CA2424812A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/18/2002CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002CA2423515A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1197493A1 Benzimidazole compounds
04/17/2002EP1197492A1 Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient
04/17/2002EP1197485A1 Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
04/17/2002EP1197226A1 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
04/17/2002EP1196412A1 Nitrogen containing heterobicycles as factor xa inhibitors
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity
04/17/2002EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors
04/17/2002EP1196390A2 Pyrazole compositions useful as inhibitors of erk
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002EP1196380A2 Indoles and indazoles for the treatment of migraine
04/17/2002EP1196169A1 Compounds having cytokine inhibitory activity
04/17/2002EP0831911B1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
04/17/2002EP0799224B1 Quinoxalines and drugs prepared therefrom
04/17/2002EP0655061B1 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric
04/17/2002CN1345319A Triazole compounds with dopamine-D3-receptor affinity
04/17/2002CN1345318A Triazole compounds with dopamine -D3-receptor affinity
04/17/2002CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method
04/16/2002US6372778 Sulfonamide inhibitors of aspartyl protease
04/16/2002US6372774 Derivatives of N-phenylpyrazoles
04/16/2002US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles
04/16/2002US6372762 Heterocyclic compounds for nervous system disorders
04/16/2002US6372759 Antithrombotic agents
04/16/2002US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor
04/16/2002US6372752 Enzyme inhibitors, respiratory system disorders, tuberculosis and mycobacterium bactericides
04/16/2002US6372751 Drugs with benzene and pyrimidine rings
04/16/2002US6372746 Derivatives of acyl-piperazinyl-pyrimidines, preparation thereof and application as medicaments
04/16/2002US6372729 Treatment of viral diseases such as aids
04/16/2002CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2114593C Indole, indazole and benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
04/16/2002CA2088980C Pro-drugs for cck antagonists
04/11/2002WO2002028861A2 Methods and compounds for treating proliferative diseases
04/11/2002WO2002028855A2 Amorphous form of cell cycle inhibitor
04/11/2002WO2002028854A1 Heteroaryl substituted hydroxyphenyltriazine uv-absorbers
04/11/2002WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators
04/11/2002WO2002028831A1 Inhibitors of prenyl-protein transferase
04/11/2002WO2002028830A1 Novel phenylalanine derivatives
04/11/2002WO2002028829A2 Peptide deformylase inhibitors
04/11/2002WO2001094317A3 Method for synthesis of substituted azole libraries
04/11/2002WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/11/2002WO2001019797A3 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/11/2002US20020042501 Antiproliferative and antitumor agents and angiogenesis inhibitors
04/11/2002US20020042442 Ureas and carbamates of N-Heterocyclic carboxylic acids and carboxylic acid isosteres
04/11/2002US20020042416 6-azauracil derivatives as IL-5 inhibitors
04/11/2002US20020042408 Antibiotic compounds